Topic: epilepsy

With more than 3,000 people with epilepsy in the U.S. dying unexpectedly each year, a spinout of the MIT Media Lab has developed a watch-sized wearable device that can automatically summon help from family members and caregivers in the event of a convulsive seizure.

The anticonvulsant approved to treat seizures in Dravet syndrome patients older than age two will launch in the U.S. January 2019.

With a nod for two rare forms of epilepsy, GW Pharma’s Epidiolex became the first cannabis-based prescription medicine in the U.S.